RENASYS◊ TOUCH Negative Pressure Wound Therapy System
A reliable, easy-to-use traditional negative pressure wound therapy (NPWT) system delivering continuous or intermittent pressure for versatile and effective therapy1-3
A reliable, easy-to-use traditional negative pressure wound therapy (NPWT) system delivering continuous or intermittent pressure for versatile and effective therapy1-3
The RENASYS System offers traditional negative pressure wound therapy that:
For inquiries, information and guidance, please contact us here.
*During an 8-week study period.
**n=210.
***n=96; compared to alternative ports.
Important Safety Information
The information herein is intended for healthcare professionals. RENASYS is contraindicated in the presence of untreated osteomyelitis, exposed arteries/veins/organs/nerves, necrotic tissue with eschar present, malignancy in the wound, non-enteric and unexplored fistulas, and exposed anastomotic sites. Excessive bleeding is a serious risk associated with the application of suction to wounds, which may result in death or serious injury. For full product and safety information, please see the Instructions for Use.
Recall and Complaints
Customer will provide such support and assistance as S+N may reasonably request in the event of a general or limited voluntary or mandatory recall of the Product(s). Customer shall promptly report any complaint in respect of the Products to complaints@smith-nephew.com.
1. Forlee M, et al. Paper presented at: EWMA; 2018; Krakow, Poland.
2. Smith+Nephew 2016. Internal report. DS.16.179.R.
3. Smith+Nephew 2016. Internal report. DS.16.174.R.
4. Hurd T, et al. Advances in Wound Care. 2017;6(1):33-37
5. Forlee M, et al. Paper presented at: Wounds UK; 2016; Harrogate, UK.
6. Hudson D, et al. Paper presented at: EWMA; 2013; Copenhagen.
7. Smith+Nephew 2012. Internal report. CSR/CT/US/11/01.
8. Carnali M, et al. Acta Vulnologica. 2016;14(1):24-39.
9. Hurd T, et al. International Wound Journal. 2010;7(6):448-455.
10. Johnson S. Journal of Wound Technology. 2008;1:30-31.